At the time of writing, Entera Bio Ltd [ENTX] stock is trading at $1.94, down -3.00%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ENTX shares have gain 10.23% over the last week, with a monthly amount drifted -15.28%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Entera Bio Ltd [NASDAQ: ENTX] stock has seen the most recent analyst activity on March 22, 2021, when Aegis Capital initiated its Buy rating and assigned the stock a price target of $12.
For the past year, the stock price of Entera Bio Ltd fluctuated between $1.50 and $3.22. Entera Bio Ltd [NASDAQ: ENTX] shares were valued at $1.94 at the most recent close of the market.
Analyzing the ENTX fundamentals
According to Entera Bio Ltd [NASDAQ:ENTX], the company’s sales were 0.12M for trailing twelve months, which represents an -100.00% plunge. Gross Profit Margin for this corporation currently stands at -0.06% with Operating Profit Margin at -19.69%, Pretax Profit Margin comes in at -20.07%, and Net Profit Margin reading is -20.19%. To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.17 and Total Capital is -0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.84 points at the first support level, and at 1.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.01, and for the 2nd resistance point, it is at 2.08.
Ratios To Look Out For
It is important to note that Entera Bio Ltd [NASDAQ:ENTX] has a current ratio of 10.83. In addition, the Quick Ratio stands at 10.83 and the Cash Ratio stands at 5.46. Considering the valuation of this stock, the price to sales ratio is 741.32, the price to book ratio is 5.82.
Transactions by insiders
Recent insider trading involved Toledano Miranda Jayne, Chief Executive Officer, that happened on Dec 29 ’25 when 11000.0 shares were purchased.
